Latest Lead News

RLF AgTech's second-year durian trial in Vietnam confirms a 38% yield increase and significant plant growth improvements, suggesting a potential 10-fold return on investment with minimal cost rise.

DigiCo Infrastructure REIT appoints Michael Juniper as CEO, signaling a strategic push into advanced data centre development amid rising cloud and AI demand. Chris Maher shifts focus to government relations, underscoring regulatory challenges ahead.

Suzerain Investment Holdings has extended its takeover offer for Entertainment Rewards Limited shares to 31 December 2025, holding over 87% of shares and urging remaining shareholders to accept promptly.

Antares Metals Limited has voluntarily suspended trading of its shares pending a significant announcement about a proposed acquisition and capital raising, expected by 8 December 2025.

Island Pharmaceuticals has been granted a pivotal US patent extending protection for its antiviral drug Galidesivir as a Covid-19 treatment until 2042, reinforcing its strategic position in the antiviral market.

Pinnacle Minerals has launched its first modern exploration program at the Antimony Queen Project in Washington State, aiming to unlock the potential of a historic antimony-gold district within a critical US minerals corridor.

AusQuest Limited has raised A$10 million through a share placement to expand drilling at its promising Cangallo copper-gold project in Peru, aiming to unlock higher-grade mineralisation.

Critical Resources Limited’s maiden drilling at the Amoco Gold-Antimony Project confirms a substantial orogenic mineralised system, underpinning its exploration model and setting the stage for further work in NSW’s New England Fold Belt.

Dexus has priced a A$500 million subordinated notes issue, enhancing its financial flexibility and extending its debt maturity profile. The move reflects strong investor demand and strategic capital management.

Algorae Pharmaceuticals has independently validated its AI-driven drug combination platform, AlgoraeOS v1, confirming its ability to predict synergistic cancer drug pairs. The company has also launched an upgraded version, AlgoraeOS v2, poised to enhance drug discovery efforts.

DorsaVi reports significant progress in its resistive RAM (RRAM) development, optimizing memory technology for integration with neuromorphic computing at the 22nm technology node. This advancement positions the company to deliver energy-efficient edge-AI solutions for wearables, robotics, and industrial safety.

NEXTDC has inked a Memorandum of Understanding with OpenAI to develop a cutting-edge sovereign AI infrastructure in Sydney, marking a major step in Australia’s digital sovereignty ambitions.